Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $233.20 | 15 | 95.6% |
| Education | $10.75 | 1 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $140.68 | 9 | $0 (2024) |
| Incyte Corporation | $36.80 | 2 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $14.78 | 1 | $0 (2022) |
| Kyowa Kirin, Inc. | $14.14 | 1 | $0 (2019) |
| Currax Pharmaceuticals LLC | $13.91 | 1 | $0 (2022) |
| ARRAY BIOPHARMA INC | $12.89 | 1 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $10.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.96 | 1 | GlaxoSmithKline, LLC. ($18.96) |
| 2023 | $49.37 | 3 | GlaxoSmithKline, LLC. ($49.37) |
| 2022 | $87.72 | 6 | GlaxoSmithKline, LLC. ($44.70) |
| 2021 | $15.00 | 1 | GlaxoSmithKline, LLC. ($15.00) |
| 2020 | $25.54 | 2 | ARRAY BIOPHARMA INC ($12.89) |
| 2019 | $14.14 | 1 | Kyowa Kirin, Inc. ($14.14) |
| 2017 | $33.22 | 2 | Incyte Corporation ($22.47) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2022 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neurology | ||||||
| 05/06/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2022 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Hematology/Oncology | ||||||
| 05/04/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2020 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2019 | Kyowa Kirin, Inc. | POTELIGEO (Drug), SANCUSO | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: MONOCLONAL ANTIBODY | ||||||
| 06/27/2017 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $10.75 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 04/23/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 2,198 | 2,668 | $95,176 | $38,481 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84165 | Protein measurement, serum | Facility | 2022 | 963 | 1,182 | $40,188 | $16,405 | 40.8% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2022 | 622 | 765 | $26,010 | $10,716 | 41.2% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2022 | 222 | 235 | $10,340 | $4,507 | 43.6% |
| 84166 | Protein measurement, body fluid | Facility | 2022 | 223 | 279 | $9,486 | $3,919 | 41.3% |
| 86335 | Immunologic analysis technique on body fluid, other fluids with concentration | Facility | 2022 | 135 | 151 | $7,248 | $2,139 | 29.5% |
| 83020 | Hemoglobin analysis and measurement, electrophoresis | Facility | 2022 | 33 | 56 | $1,904 | $795.34 | 41.8% |
About Li Jin
Li Jin is a Clinical Laboratory Director, Non-physician healthcare provider based in Grand Blanc, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922121102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Li Jin has received a total of $243.95 in payments from pharmaceutical and medical device companies, with $18.96 received in 2024. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($233.20).
As a Medicare-enrolled provider, Jin has provided services to 2,198 Medicare beneficiaries, totaling 2,668 services with total Medicare billing of $38,481. Data is available for 1 year (2022–2022), covering 6 distinct procedure/service records.
Practice Information
- Specialty Clinical Laboratory Director, Non-physician
- Other Specialties Non-physician|Anatomic Pathology & Clinical Pathology
- Location Grand Blanc, MI
- Active Since 04/10/2007
- Last Updated 09/19/2023
- Taxonomy Code 247ZC0005X
- Entity Type Individual
- NPI Number 1922121102
Products in Payments
- ZEJULA (Drug) $87.58
- JEMPERLI (Biological) $53.10
- JAKAFI (Drug) $36.80
- LIBTAYO (Biological) $14.78
- POTELIGEO (Drug) $14.14
- ONZETRA XSAIL (Drug) $13.91
- BRAFTOVI (Drug) $12.89
- FERAHEME (Drug) $10.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.